Showing results (881-890 of 1,840) with videos related to

Sort By:
Pageof 184
ESMO Open|December 23, 2022
Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer-results from an international, multicenter analysis coordinated by the AGMT Study GroupS P Gampenrieder, V Dezentjé, M Lambertini, et al.
ESMO Open|June 21, 2021
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II studyK Hotta, S Saeki, M Yamaguchi, et al.
ESMO Open|December 15, 2022
MOVIE: a phase I, open-label, multicenter study to evaluate the safety and tolerability of metronomic vinorelbine combined with durvalumab plus tremelimumab in patients with advanced solid tumorsC Vicier, N Isambert, C Cropet, et al.
ESMO Open|December 17, 2022
The association between UGT1A1 polymorphisms and treatment toxicities of liposomal irinotecanY-Y Su, N-J Chiang, J S Chang, et al.
ESMO Open|December 17, 2022
Proteomic analysis of brain metastatic lung adenocarcinoma reveals intertumoral heterogeneity and specific alterations associated with the timing of brain metastasesN Woldmar, A Schwendenwein, M Kuras, et al.
ESMO Open|January 12, 2023
Twelve ESMO Congress 2022 breakthroughs: practicing oncologists' perceptions and potential application on presented dataH K van Halteren, J Bennouna, B Brasiuniene, et al.
ESMO Open|June 13, 2022
Impact of smoking status on the relative efficacy of the EGFR TKI/angiogenesis inhibitor combination therapy in advanced NSCLC-a systematic review and meta-analysisU Dafni, R A Soo, S Peters, et al.
ESMO Open|June 1, 2022
Real-life daily activity: the impact of misbeliefs on quality of life among cancer patientsE Shachar, S P Hasson, L Ferro, et al.
ESMO Open|June 2, 2022
Efficacy of tyrosine kinase inhibitors for the treatment of patients with HER2-positive breast cancer with brain metastases: a systematic review and meta-analysisG Nader-Marta, D Martins-Branco, E Agostinetto, et al.
ESMO Open|June 2, 2022
Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer RegistryE Laakmann, I Witzel, T Neunhöffer, et al.
Pageof 184